Fund HoldingsSaturn V Capital Management LP

Total Portfolio Value
$246.76M
Total Bought
$99.15M
Total Sold
$51.13M
Net Transaction
+$48.02M
Filing Period:
Securities
SharesValue ($K)
Q1 2025
Q2 2025
Change
Q1 2025
Q2 2025
Weight (%)
Change
JAZZ PHARMACEUTICALS PLC(JAZZ)0206,952+206,952021,9628.90%+21,962
DYNE THERAPEUTICS INC(DYN)01,455,429+1,455,429013,8565.62%+13,856
AMYLYX PHARMACEUTICALS INC(AMLX)2,426,4363,260,570+834,1348,59020,9008.47%+12,311
LENZ THERAPEUTICS INC0342,312+342,312010,0334.07%+10,033
VAXCYTE INC(PCVX)232,295544,221+311,9268,77117,6937.17%+8,921
COGENT BIOSCIENCES INC(COGT)1,480,0202,297,524+817,5048,86516,4966.69%+7,631
NEUROCRINE BIOSCIENCES INC(NBIX)058,181+58,18107,3132.96%+7,313
CELCUITY INC(CELC)1,093,6771,185,520+91,84311,05715,8276.41%+4,770
CENTESSA PHARMACEUTICALS PLC448,692793,327+344,6356,45210,4244.22%+3,972
OCULAR THERAPEUTIX INC(OCUL)598,191728,576+130,3854,3856,7612.74%+2,376
NEWAMSTERDAM PHARMA COMPANY
ORDINARY SHARES
116,353220,695+104,3422,3823,9971.62%+1,615
ABIVAX SA(ABVX)552,926622,479+69,5533,4564,7621.93%+1,306
REPLIMUNE GROUP INC(REPL)0128,917+128,91701,1980.49%+1,198
CG ONCOLOGY INC(CGON)577,696586,647+8,95114,14815,2536.18%+1,105
XENON PHARMACEUTICALS INC(XENE)413,711468,364+54,65313,88014,6605.94%+780
MOONLAKE IMMUNOTHERAPEUTICS(MLTX)343,849290,784-53,06513,43413,7255.56%+291
INOZYME PHARMA INC499,2540-499,2544540-454
MERUS N V323,211224,260-98,95113,60411,7964.78%-1,808
SILENCE THERAPEUTICS PLC732,46334,737-697,7262,0662010.08%-1,864
CRINETICS PHARMACEUTICALS IN(CRNX)59,0170-59,0171,9790-1,979
KALVISTA PHARMACEUTICALS INC255,06062,793-192,2672,9437100.29%-2,234
ARGENX SE(ARGX)13,86210,285-3,5778,2045,6692.30%-2,535
CONTINEUM THERAPEUTICS INC560,979319,348-241,6313,9161,2680.51%-2,648
DISC MEDICINE INC(IRON)518,177396,115-122,06225,72220,9788.50%-4,744
SYNDAX PHARMACEUTICALS INC(SNDX)1,041,280500,551-540,72912,7924,6881.90%-8,104
ASCENDIS PHARMA A/S(ASND)199,26438,191-161,07331,0576,5922.67%-24,466
Page 1 of 1